ReviewJournal of lipids2018

Cardiovascular Outcomes of PCSK9 Inhibitors: With Special Emphasis on Its Effect beyond LDL-Cholesterol Lowering.

Dhrubajyoti Bandyopadhyay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.